Literature DB >> 7579336

Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK.

S E Nicholson1, U Novak, S F Ziegler, J E Layton.   

Abstract

The protein tyrosine kinases JAK1 and JAK2 are phosphorylated tyrosine after the interaction of granulocyte colony-stimulating factor (G-CSF) with its transmembrane receptor. So too is Stat3, a member of the STAT family of transcriptional activators thought to be activated by the JAK kinases. Truncated G-CSF receptor (G-CSF-R) mutants were used to determine the different regions of the cytoplasmic domain necessary for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. We have shown that G-CSF-induced tyrosine phosphorylation and kinase activation of JAK2 requires the membrane proximal 57 amino acids of the cytoplasmic domain. In contrast, maximal Stat3 tyrosine phosphorylation required amino acids 96 to 183 of the G-CSF-R cytoplasmic domain, Stat3 DNA binding could occur with a receptor truncated 96 amino acids from the transmembrane domain and containing a single tyrosine residue, but was reduced in comparison with the full-length receptor. Together with the tyrosine phosphorylation of Stat3, this finding suggests that additional Stat3 does not appear to be required for proliferation. MAP kinase tyrosine phosphorylation correlated with both the proliferative response and JAK2 activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579336

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Differentiation-Associated Expression of Conventional Protein Kinase C Isoforms in Primary Cultures of Bone Marrow Cells Induced by M-CSF and G-CSF.

Authors:  Xiaohua Li; Hong Meng; Ben D Chen
Journal:  Am J Biomed Sci       Date:  2009-01-01

2.  Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway.

Authors:  O Rausch; C J Marshall
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation.

Authors:  Haijiao Zhang; Cody Coblentz; Kevin Watanabe-Smith; Sophie Means; Jasmine Means; Julia E Maxson; Jeffrey W Tyner
Journal:  J Biol Chem       Date:  2018-03-23       Impact factor: 5.157

4.  Functional analysis of Asb-1 using genetic modification in mice.

Authors:  B T Kile; D Metcalf; S Mifsud; L DiRago; N A Nicola; D J Hilton; W S Alexander
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

Review 5.  The colony-stimulating factors and cancer.

Authors:  Donald Metcalf
Journal:  Cancer Immunol Res       Date:  2013-12       Impact factor: 11.151

6.  The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.

Authors:  Zhihe Kuang; Rowena S Lewis; Joan M Curtis; Yifan Zhan; Bernadette M Saunders; Jeffrey J Babon; Tatiana B Kolesnik; Andrew Low; Seth L Masters; Tracy A Willson; Lukasz Kedzierski; Shenggen Yao; Emanuela Handman; Raymond S Norton; Sandra E Nicholson
Journal:  J Cell Biol       Date:  2010-07-05       Impact factor: 10.539

7.  Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.

Authors:  S E Nicholson; T A Willson; A Farley; R Starr; J G Zhang; M Baca; W S Alexander; D Metcalf; D J Hilton; N A Nicola
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

8.  Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo.

Authors:  M A Goldsmith; A Mikami; Y You; K D Liu; L Thomas; P Pharr; G D Longmore
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

Review 9.  Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.

Authors:  Athanasia D Panopoulos; Stephanie S Watowich
Journal:  Cytokine       Date:  2008-04-08       Impact factor: 3.861

10.  Granulocyte colony stimulating factor increases drug resistance of leukaemic blast cells to daunorubicin.

Authors:  László Márkász; György Hajas; Andrea Kiss; Beáta Lontay; Eva Rajnavölgyi; Ferenc Erdodi; Eva Oláh
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.